Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?

To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1999-02, Vol.83 (3), p.461-462
Main Authors: Vančura, Vlastimil, Hubáček, Jaroslav, Málek, Ivan, Gebauerová, Marie, Pit’ha, Jan, Dorazilová, Zora, Langová, Martina, Želı́zko, Michael, Poledne, Rudolf
Format: Article
Language:English
Subjects:
Adult
Alleles
Biological and medical sciences
Cardiology. Vascular system
Cardiomyopathy, Dilated - complications
Cardiomyopathy, Dilated - enzymology
Cardiomyopathy, Dilated - surgery
Disease Progression
DNA - biosynthesis
Female
Follow-Up Studies
Gene Frequency
Genetic Markers
Genotype
Heart
Heart Failure - enzymology
Heart Failure - etiology
Heart Failure - surgery
Heart Transplantation
Humans
Male
Medical sciences
Middle Aged
Myocarditis. Cardiomyopathies
Peptidyl-Dipeptidase A - genetics
Polymorphism, Genetic
Prognosis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3
cites cdi_FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3
container_end_page 462
container_issue 3
container_start_page 461
container_title The American journal of cardiology
container_volume 83
creator Vančura, Vlastimil
Hubáček, Jaroslav
Málek, Ivan
Gebauerová, Marie
Pit’ha, Jan
Dorazilová, Zora
Langová, Martina
Želı́zko, Michael
Poledne, Rudolf
description To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was found, but when compared with the population sample there were fewer ID heterozygotes detected; no significant influence of ACE polymorphism on the course of the disease before transplantation was found.
doi_str_mv 10.1016/S0002-9149(98)00889-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69615162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914998008893</els_id><sourcerecordid>69615162</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3</originalsourceid><addsrcrecordid>eNqFkU2PFCEQhonRuOPqT9BwMEYPrdAfDJw2Zv1MNvGgnkktFNOYbhiBXtP-GH-rzM5EvXkiFZ56q-p9CXnM2UvOuHj1mTHWNor36rmSLxiTUjXdHbLhcqsarnh3l2z-IGfkQc7fasn5IO6TM87Ytm37YUN-vYmYKYSdjwVD9qExMdxgKj7sKIaf64x0H6d1jmk_-jxTH9y0YDBIy4jUTD54AxOdIXiHuUDxMVQ9S_cp7hLmfKijoyNCKtSBn5aEVYXuK4qhZPrDl5FaP0FBSw0k6-O8xvo9rhcPyT0HU8ZHp_ecfH339svlh-bq0_uPl6-vGtOxoTSwNaJt0QgnAF07yIFDb4WRbDBgGMBguVN9C_YaoRMgjGOVBNEKCbLH7pw8O-rWrb8v9Q49-2xwmiBgXLIWSvCBi7aCwxE0Keac0Ol98jOkVXOmD8Ho22D0wXWtpL4NRne178lpwHI9o_2n65hEBZ6eAMjVUJcgGJ__ckIopmTFLo4YVjduPCadjT_EYX1CU7SN_j-b_AYs8rBp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69615162</pqid></control><display><type>article</type><title>Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?</title><source>ScienceDirect Freedom Collection</source><creator>Vančura, Vlastimil ; Hubáček, Jaroslav ; Málek, Ivan ; Gebauerová, Marie ; Pit’ha, Jan ; Dorazilová, Zora ; Langová, Martina ; Želı́zko, Michael ; Poledne, Rudolf</creator><creatorcontrib>Vančura, Vlastimil ; Hubáček, Jaroslav ; Málek, Ivan ; Gebauerová, Marie ; Pit’ha, Jan ; Dorazilová, Zora ; Langová, Martina ; Želı́zko, Michael ; Poledne, Rudolf</creatorcontrib><description>To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was found, but when compared with the population sample there were fewer ID heterozygotes detected; no significant influence of ACE polymorphism on the course of the disease before transplantation was found.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(98)00889-3</identifier><identifier>PMID: 10072245</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Alleles ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiomyopathy, Dilated - complications ; Cardiomyopathy, Dilated - enzymology ; Cardiomyopathy, Dilated - surgery ; Disease Progression ; DNA - biosynthesis ; Female ; Follow-Up Studies ; Gene Frequency ; Genetic Markers ; Genotype ; Heart ; Heart Failure - enzymology ; Heart Failure - etiology ; Heart Failure - surgery ; Heart Transplantation ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocarditis. Cardiomyopathies ; Peptidyl-Dipeptidase A - genetics ; Polymorphism, Genetic ; Prognosis ; Retrospective Studies</subject><ispartof>The American journal of cardiology, 1999-02, Vol.83 (3), p.461-462</ispartof><rights>1999 Excerpta Medica Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3</citedby><cites>FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1669098$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10072245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vančura, Vlastimil</creatorcontrib><creatorcontrib>Hubáček, Jaroslav</creatorcontrib><creatorcontrib>Málek, Ivan</creatorcontrib><creatorcontrib>Gebauerová, Marie</creatorcontrib><creatorcontrib>Pit’ha, Jan</creatorcontrib><creatorcontrib>Dorazilová, Zora</creatorcontrib><creatorcontrib>Langová, Martina</creatorcontrib><creatorcontrib>Želı́zko, Michael</creatorcontrib><creatorcontrib>Poledne, Rudolf</creatorcontrib><title>Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was found, but when compared with the population sample there were fewer ID heterozygotes detected; no significant influence of ACE polymorphism on the course of the disease before transplantation was found.</description><subject>Adult</subject><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiomyopathy, Dilated - complications</subject><subject>Cardiomyopathy, Dilated - enzymology</subject><subject>Cardiomyopathy, Dilated - surgery</subject><subject>Disease Progression</subject><subject>DNA - biosynthesis</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gene Frequency</subject><subject>Genetic Markers</subject><subject>Genotype</subject><subject>Heart</subject><subject>Heart Failure - enzymology</subject><subject>Heart Failure - etiology</subject><subject>Heart Failure - surgery</subject><subject>Heart Transplantation</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Peptidyl-Dipeptidase A - genetics</subject><subject>Polymorphism, Genetic</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkU2PFCEQhonRuOPqT9BwMEYPrdAfDJw2Zv1MNvGgnkktFNOYbhiBXtP-GH-rzM5EvXkiFZ56q-p9CXnM2UvOuHj1mTHWNor36rmSLxiTUjXdHbLhcqsarnh3l2z-IGfkQc7fasn5IO6TM87Ytm37YUN-vYmYKYSdjwVD9qExMdxgKj7sKIaf64x0H6d1jmk_-jxTH9y0YDBIy4jUTD54AxOdIXiHuUDxMVQ9S_cp7hLmfKijoyNCKtSBn5aEVYXuK4qhZPrDl5FaP0FBSw0k6-O8xvo9rhcPyT0HU8ZHp_ecfH339svlh-bq0_uPl6-vGtOxoTSwNaJt0QgnAF07yIFDb4WRbDBgGMBguVN9C_YaoRMgjGOVBNEKCbLH7pw8O-rWrb8v9Q49-2xwmiBgXLIWSvCBi7aCwxE0Keac0Ol98jOkVXOmD8Ho22D0wXWtpL4NRne178lpwHI9o_2n65hEBZ6eAMjVUJcgGJ__ckIopmTFLo4YVjduPCadjT_EYX1CU7SN_j-b_AYs8rBp</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Vančura, Vlastimil</creator><creator>Hubáček, Jaroslav</creator><creator>Málek, Ivan</creator><creator>Gebauerová, Marie</creator><creator>Pit’ha, Jan</creator><creator>Dorazilová, Zora</creator><creator>Langová, Martina</creator><creator>Želı́zko, Michael</creator><creator>Poledne, Rudolf</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990201</creationdate><title>Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?</title><author>Vančura, Vlastimil ; Hubáček, Jaroslav ; Málek, Ivan ; Gebauerová, Marie ; Pit’ha, Jan ; Dorazilová, Zora ; Langová, Martina ; Želı́zko, Michael ; Poledne, Rudolf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiomyopathy, Dilated - complications</topic><topic>Cardiomyopathy, Dilated - enzymology</topic><topic>Cardiomyopathy, Dilated - surgery</topic><topic>Disease Progression</topic><topic>DNA - biosynthesis</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gene Frequency</topic><topic>Genetic Markers</topic><topic>Genotype</topic><topic>Heart</topic><topic>Heart Failure - enzymology</topic><topic>Heart Failure - etiology</topic><topic>Heart Failure - surgery</topic><topic>Heart Transplantation</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Peptidyl-Dipeptidase A - genetics</topic><topic>Polymorphism, Genetic</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vančura, Vlastimil</creatorcontrib><creatorcontrib>Hubáček, Jaroslav</creatorcontrib><creatorcontrib>Málek, Ivan</creatorcontrib><creatorcontrib>Gebauerová, Marie</creatorcontrib><creatorcontrib>Pit’ha, Jan</creatorcontrib><creatorcontrib>Dorazilová, Zora</creatorcontrib><creatorcontrib>Langová, Martina</creatorcontrib><creatorcontrib>Želı́zko, Michael</creatorcontrib><creatorcontrib>Poledne, Rudolf</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vančura, Vlastimil</au><au>Hubáček, Jaroslav</au><au>Málek, Ivan</au><au>Gebauerová, Marie</au><au>Pit’ha, Jan</au><au>Dorazilová, Zora</au><au>Langová, Martina</au><au>Želı́zko, Michael</au><au>Poledne, Rudolf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>83</volume><issue>3</issue><spage>461</spage><epage>462</epage><pages>461-462</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was found, but when compared with the population sample there were fewer ID heterozygotes detected; no significant influence of ACE polymorphism on the course of the disease before transplantation was found.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10072245</pmid><doi>10.1016/S0002-9149(98)00889-3</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1999-02, Vol.83 (3), p.461-462
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_69615162
source ScienceDirect Freedom Collection
subjects Adult
Alleles
Biological and medical sciences
Cardiology. Vascular system
Cardiomyopathy, Dilated - complications
Cardiomyopathy, Dilated - enzymology
Cardiomyopathy, Dilated - surgery
Disease Progression
DNA - biosynthesis
Female
Follow-Up Studies
Gene Frequency
Genetic Markers
Genotype
Heart
Heart Failure - enzymology
Heart Failure - etiology
Heart Failure - surgery
Heart Transplantation
Humans
Male
Medical sciences
Middle Aged
Myocarditis. Cardiomyopathies
Peptidyl-Dipeptidase A - genetics
Polymorphism, Genetic
Prognosis
Retrospective Studies
title Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A14%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20angiotensin-converting%20enzyme%20polymorphism%20influence%20the%20clinical%20manifestation%20and%20progression%20of%20heart%20failure%20in%20patients%20with%20dilated%20cardiomyopathy?&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Van%C4%8Dura,%20Vlastimil&rft.date=1999-02-01&rft.volume=83&rft.issue=3&rft.spage=461&rft.epage=462&rft.pages=461-462&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(98)00889-3&rft_dat=%3Cproquest_cross%3E69615162%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c305t-a7c622ec6f6aef25851a4d6c805cac0aa5d1f942adbea36a6cf06aea6268a84e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69615162&rft_id=info:pmid/10072245&rfr_iscdi=true